Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 15, Art. 9 (pp. 86-99)    |    2014       

»

Atopic dermatitis: etiopathogenic factors of microflora, tactics of therapy

Naumenko M.A.,Raznatovskiy K.I., Kvetnaya A.S.

¹-NORTH-WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I.I.MECHNIKOV:CHAIR OF DERMATOVENEROLOGY, ST.PETERSBURG,RUSSIA
²- RESEARCH INSTITUTE OF CHILDHOOD INFECTIONS, ST.PETERSBURG,RUSSIA

Brief summary

In this article presents the results of research done on etiopathogenetic role of pathogenic microflora of the skin and mucosal of the oropharynx in patients with atopic dermatitis. Proposed a strategy for the integrated restoration of the epidermal barrier using immunocorrective therapy based on an assessment of indicators of anti-infective resistance of the skin and mucosal of the oropharynx in patients with this pathology.


Key words

atopic dermatitis, microflora of the skin and mucosal of the oropharynx , anti-infective resistance, immunotherapy

Reference list

1. Mancini A.J., Kaulback K., Chamlin S.L. The socioeconomic impact of atopic dermatitis in the United States: A systematic review // Pediatr. Dermatol. - 2008. – Vol.25. – P.1-6.


2. Leung D.Y., Biber T. Atopic dermatitis // Lancet. - 2003. – Vol.361. – P.151-160.


3. Palmer C.N.A., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis // Nat Genet. – 2006. – Vol.38. – P.441–446.


4. Darsow U., Wollenberg A., Simon D., Taieb A., Werfel T., Oranje A. et al. ETFAD⁄EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis the European Task Force on Atopic Dermatitis ⁄EADV Eczema Task Force // JEADV. – 2010. – Vol. 24. – P.317–328


5. Jones S.M. Triggers of atopic dermatitis. Immunol. and Allergol // Clinics of North America. – 2002. – Vol.1 (22). – P.55–72.


6. Voronina V.R., Pampyra A.N., Fedenko E.S. Osobennosti mikrobiocenoza koji bolnih atopicheskim dermatitom i terapiya ego oslojnenii // Rossiiskii allergologicheskii jyrnal. - 2007. - № 3. - S.3–11.


7. Guzic T.J., Bzowska M., Kasprowicz A. et al. Persistent skin colonization with Staphylococccus aureus in atopic dermatitis :relationship to clinical and immunological parameters // Clin. Exp. Allergy. - 2005. – Vol. 35. – P.448-455.


8. Breuer K., S Ha, Kapp A., Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis // Br. J. Dermatol. - 2002. – Vol.147. – P.55-61.


9. Nilsson E., Henning C., Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis // J. Am. Acad. Dermatol. – 1992. – Vol.27. – P.29-34.


10. Severity Scoring of Atopic Dermatitis: The SCORAD INDEX Consensus Report of the Europian Task Forse on Atopic Dermatitus // Dermatology. - 1993. – Vol.186. – P.23-31.


11. Chychalin A.G., Kolganova N.A., Gaichieva Z.N. Ocenka effektivnosti i bezopasnosti preparata ryzam pri lechenii atopicheskogo dermatita // Vestnik dermatologii i venerologii. – 2005. - № 4. – S.33-37.


12. Naymenko M.A., Alekseev M.E., Popova E.V., Kvetnaya A.S. Sposob prognozirovaniya techeniya atopicheskogo dermatita. Patent na izobretenie №2310195 ot 10.11.07.


13. Matsui K., Nishikawa A., Suto H. et al. Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis patients // Microbiol. Immunol. - 2000. – Vol. 44. – P.945-994.


14. Rippke F., Schreiner V., Doering T., Maibach H. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus // Am. J. Clin. Dermatol. - 2004. – Vol.5. – P.217-223.